Cargando…
A rare IL33 loss-of-function mutation reduces blood eosinophil counts and protects from asthma
IL-33 is a tissue-derived cytokine that induces and amplifies eosinophilic inflammation and has emerged as a promising new drug target for asthma and allergic disease. Common variants at IL33 and IL1RL1, encoding the IL-33 receptor ST2, associate with eosinophil counts and asthma. Through whole-geno...
Ejemplares similares
-
Eighty-eight variants highlight the role of T cell regulation and airway remodeling in asthma pathogenesis
por: Olafsdottir, Thorunn A., et al.
Publicado: (2020) -
Common and rare variants associating with serum levels of creatine kinase and lactate dehydrogenase
por: Kristjansson, Ragnar P., et al.
Publicado: (2016) -
Genetic architecture of band neutrophil fraction in Iceland
por: Oskarsson, Gudjon R., et al.
Publicado: (2022) -
The rate of meiotic gene conversion varies by sex and age
por: Halldorsson, Bjarni V., et al.
Publicado: (2016) -
Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland
por: Björnsson, Eythór, et al.
Publicado: (2021)